Advocacy - Government Coverage and Reimbursement Policies Take Action Federal Advocacy State Advocacy Local Advocacy Protect Access and Innovation CLSAPAC CLSA Capitol Connection Become an Advocate Policy & Advocacy News Letters, Testimony and Comments December 30, 2013HR 3681 Accelerating Innovation in Medicine Act of 2013 April 16, 2013HR 1588 Medicare Drug Savings Act of 2013 April 16, 2013S 740 Medicare Drug Savings Act of 2013 January 23, 2013HR 351 Protecting Seniors’ Access to Medicare Act of 2013 June 28, 2017Bipartisan Letter to Veterans Administration on Medical Device Late Payments – June 2017 June 8, 2017269 Health Care and Patient Advocacy Groups Ask Secretary Price to Oppose Harmful Cuts to Part B – June 2017 February 15, 2017CLSA Letter to Rep. Raul Ruiz in Support of Bill to Repeal the Independent Payment Advisory Board (H.R. 849) – February 2017 November 29, 2016600 Organizations Urge Repeal of the Independent Payment Advisory Board (IPAB)- November 2016 September 12, 2016CLSA Comments Regarding National Call for Proposed Improvements to ICER Value Assessment Framework – September 2016 July 20, 2016Patient Group Endorsement Letter – HR 5009 – The Ensuring Access to Critical Breakthrough Products Act – July 2016 July 6, 2016CLSA Endorsement Letter – HR 1427 – Medicare CGM Access Act – July 2016 June 20, 2016NIH/HHS Response to March-In Citizens Petition & Request for Public Hearing on Xtandi (enzalutamide) – June 2016 June 6, 2016State Association Endorsement Letter – HR 5009 – The Ensuring Access to Critical Breakthrough Products Act – June 2016 May 31, 2016CMS Response to Congressional Part B Letter Urging Withdrawal – May 2016 May 16, 2016Democratic Congressional Letter to CMS Expressing Concerns on Part B Rule – May 2016 May 13, 2016Congressional Letter to CMS Expressing Serious Concerns Over CMS Proposal – May 2016 May 9, 2016CLSA Comments to CMS Requesting Withdrawal of CMS Part B Proposed Rule – May 2016 May 9, 201643 State Associations Urge CMS to Withdraw Medicare Part B Proposed Rule – May 2016 May 9, 2016Rep. Scott Peters Letter to CMS Requesting Withdrawal of CMS Part B Rule – May 2016 May 2, 2016Bipartisan Congressional Letter Urging Withdrawal of CMS Part B Proposed Rule – April 2016 April 21, 2016CLSA Backgrounder on the Ensure Patient Access to Critical Breakthrough Products Act (H.R. 5009) – April 2016 April 20, 2016CLSA Endorsement Letter – HR 5009 – The Ensuring Access to Critical Breakthrough Products Act – April 2016 April 14, 2016California Patient & Provider Group Letter Opposing CMS Part B Rule – April 2016 March 17, 2016CLSA Endorsement Letter – HR 4714 – The Removing Barrier to Clinical Research Act – March 2016 March 17, 2016316 Health Care and Patient Advocacy Groups Ask Congress to Oppose CMS Part B Drug Experiment – March 2016 March 2, 2016HHS Response to Rep. Doggett Declining to Issue Guidance on the Use of March-In Rights – March 2016 January 25, 2016CLSA Response to March In Letter Rights – January 2016 May 5, 2015Letter From 500+ Stakeholder Groups in Support of IPAB Repeal — May 2015 March 4, 2015Stakeholder Letter to HHS Secretary In Support of Medicare Part D — March 2015 October 2, 2014Bipartisan Congressional Letter Urging Medicare Coverage Of FDA-Approved Obesity Medications — September 2014 August 8, 2014CHI and Stakeholder Comments to DHCS on Medi-Cal Coverage and Access Policies for Innovative Therapies (SB 870) — August 2014 March 11, 2014CHI Letter to Rep. Renee Ellmers in support of Keep the Promise to Seniors Act (H.R. 4160), Blocking CMS from Implementing Part D Proposed Rule March 4, 2014Bipartisan Letter from House Energy & Commerce, Ways & Means Committee Members Opposing CMS’ Proposed Changes to Six Protected Classes — March 4, 2014 February 18, 2014Stakeholder Letter Addressing Concerns Over CMS Medicare Advantage and Part D Proposed Rule — February 18, 2014 February 13, 2014House Republican Leadership Letter to President Obama Opposing Changes to Medicare Advantage and Part D Prescription Drug Program — February 13, 2014 February 5, 2014Senate Finance Committee Bipartisan Letter Opposing Elimination of Six Protected Classes of Prescription Drugs from Medicare Part D — February 5, 2014 November 18, 2013House Democratic Letter Urging Protection of Rare Disease Patient Interests Under Affordable Care Act — November 2013 October 7, 2013Bipartisan California Delegation Letter to CMS Protecting Diabetic Patient Access to Advanced Wound Healing Therapies — October 7, 2013 September 26, 2013Congressional Letter to President Obama Supporting Medicare Part D and Opposing Proposed Rebates — September 26, 2013 September 4, 2013HHS Office of Inspector General (OIG) Report Examines Pros, Cons Of Mandatory Manufacturer Part B Drug Rebates — September 2013 August 2, 2013Congressional Letter to Leadership Opposing Medicare Part D Rebates — August 2, 2013 June 27, 2013Bipartisan House Letter Opposing Medicare Part B Payment Cuts — June 27, 2013 May 9, 2013CHI Statement in Opposition to H.R. 1588 S. 740, to Require Manufacturers to Provide New Part D Drug Rebates — May 9, 2013 April 25, 2013CHI Letter — Support of HR351, to Repeal the Independent Payment Advisory Board (IPAB) — April 25, 2013 April 14, 2013CHI Summary of Highlights: President Barack Obama’s Fiscal Year 2014 Budget Request — April 14, 2013 March 4, 2013CHI Letter Addressing Opposition to Cuts in Medicare Part B Program — March 4, 2013
